Cite
HARVARD Citation
Calvente, L. et al. (2020). Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma. British journal of haematology. pp. 864-868. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Calvente, L. et al. (2020). Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma. British journal of haematology. pp. 864-868. [Online].